SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Swiss Re AG (SSREY) trades at a trailing P/E of 10.7, forward P/E of 10.8. Trailing earnings yield is 9.34%, forward earnings yield 9.28%. PEG 0.21 (Peter Lynch undervalued ≤1.0).
Criteria proven by this page:
- VALUE (100/100, Pass) — P/E is below market average (10.7); PEG ≤ 1.0 — Peter Lynch undervalued (0.21); earnings yield beats bond yields (9.34%).
- PEG Ratio 0.21 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
- Trailing Earnings Yield 9.34% — exceeds typical bond yields (~4.3%), making equity attractive vs fixed income.
Overall SharesGrow Score: 78/100 with 5/7 criteria passed.
SharesGrow 7-Criteria Score
✓
VALUE
100/100
Price-to-Earnings & upside
Proven by this page
✓
HEALTH
100/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — SSREY
Valuation Multiples
P/E (TTM)10.7
Forward P/E10.8
PEG Ratio0.21
Forward PEG2.20
P/B Ratio0.00
P/S Ratio1.06
EV/EBITDA0.0
Per Share Data
EPS (TTM)$3.99
Forward EPS (Est.)$3.97
Book Value / Share$0.00
Revenue / Share$40.32
FCF / Share$0.00
Yields & Fair Value
Earnings Yield9.34%
Forward Earnings Yield9.28%
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2016 |
$2.41 |
$43.81B |
$3.56B |
8.1% |
| 2017 |
$0.26 |
$42.5B |
$398M |
0.9% |
| 2018 |
$0.37 |
$37.06B |
$462M |
1.2% |
| 2019 |
$0.60 |
$49.33B |
$727M |
1.5% |
| 2020 |
$-0.76 |
$43.35B |
$-878M |
-2% |
| 2021 |
$1.20 |
$46.74B |
$1.44B |
3.1% |
| 2022 |
$0.39 |
$46.04B |
$472M |
1% |
| 2023 |
$2.62 |
$49.73B |
$3.21B |
6.5% |
| 2024 |
$2.63 |
$8.73B |
$3.24B |
37.1% |
| 2025 |
$3.99 |
$48.19B |
$4.76B |
9.9% |
